FDA 483 - Saranya Chumsri MD - September 10, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Saranya Chumsri MD, a Sponsor-Investigator in Jacksonville, FL, revealed a significant failure to adhere to human subject protection protocols. The firm failed to promptly report critical information, specifically findings from a Data Safety Monitoring Committee re-audit and the temporary closure of a clinical study, to the Institutional Review Board (IRB). This oversight led to the IRB suspending subject enrollment for the study, highlighting a serious lapse in regulatory compliance.
ID · b031b634-254c-40a2-be42-48431625de46